Cognizant in Talks to Back Sarvam at $3.5–4 Billion Valuation — Startup Funding India, October 2026

Nasdaq-listed IT services company Cognizant is in talks to participate in Indian AI startup Sarvam’s latest financing round, which is expected to value the company at $3.5–4 billion, according to The Economic Times on 28 October 2026, citing people aware of the matter. The talks are the newest development in startup funding in India’s biggest AI story — and a sign of how the lines between IT services giants and AI labs are blurring.

Sarvam is seeking to raise around $300 million in fresh funds, ET had reported on 13 October, and Cognizant may end up acquiring a small stake in the company, the report said. A $3.5–4 billion valuation would be more than double Sarvam’s previous round valuation. Crucially, this is reported as talks, not a closed deal — terms can still change, and neither company has confirmed the investment.

Why Cognizant would want in

The report frames the potential investment against a strategic anxiety: advances in agentic AI are raising questions about the future of the IT services industry, as AI agents grow increasingly capable of automating software development, application maintenance and back-office work — the bread and butter of traditional outsourcing. For a services giant, a stake in a frontier AI lab is both a hedge and a front-row seat to the technology reshaping its own market.

Sarvam was founded by Vivek Raghavan and Pratyush Kumar and is building AI models and platforms for India. A services incumbent joining its cap table would also be a distribution story: Cognizant’s enterprise relationships could carry Sarvam’s technology into global clients far faster than a pure product push.

What founders should read into it

When incumbents start investing in the disruptors, the market is telling you the disruption is real — and that partnerships with the old guard can be a go-to-market channel, not just an exit path. But the caution applies too: until a round closes, a reported valuation is a headline, not a term sheet. Founders should treat talks-stage numbers as signal about direction, not as a benchmark for their own pricing.